About Bioxydyn
Bioxydyn is a company based in Manchester (United Kingdom) founded in 2009. Bioxydyn has raised $1.93 million across 1 funding round from investors including The North West Fund and MTI Partners. The company has 8 employees as of December 31, 2021. Bioxydyn offers products and services including Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and Neuroimaging Services. Bioxydyn operates in a competitive market with competitors including Polarean Imaging, Tomophase, Fluidda, Cyclopharm and Elaatech, among others.
- Headquarter Manchester, United Kingdom
- Employees 8 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bioxydyn Limited
- Date of Incorporation 05 Mar, 2009
- Jurisdiction MANCHESTER, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$1.93 M (USD)
in 1 rounds
-
Latest Funding Round
$1.93 M (USD), Series A
Oct 04, 2012
-
Investors
The North West Fund
& 1 more
-
Employee Count
8
as on Dec 31, 2021
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioxydyn
Bioxydyn offers a comprehensive portfolio of products and services, including Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and Neuroimaging Services.
Delivers MRI-based biomarkers for assessing disease and drug effects in research.
Offers MRI methods for evaluating lung function in respiratory diseases.
Provides functional MRI biomarkers to inform tumor therapy effectiveness.
Uses quantitative MRI for studying inflammation in various diseases.
Applies MRI techniques for conditions like multiple sclerosis and dementia.
Measures liver function using dynamic contrast-enhanced MRI methods.
Funding Insights of Bioxydyn
Bioxydyn has successfully raised a total of $1.93M through 1 strategic funding round. The most recent funding activity was a Series A round of $1.93 million completed in October 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bioxydyn
Bioxydyn has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include The North West Fund and MTI Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Bioxydyn
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bioxydyn
Investment portfolio details for Bioxydyn
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bioxydyn
Detailed financials for Bioxydyn
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bioxydyn Comparisons
Peer comparison for Bioxydyn
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bioxydyn
Bioxydyn operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Polarean Imaging, Tomophase, Fluidda, Cyclopharm and Elaatech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Noble gas polarizers for hyperpolarized pulmonary MRI are developed.
|
|
| Locked | Locked | Locked |
Endoscopic devices for respiratory disorders are developed using optical interferometry.
|
|
| Locked | Locked | Locked |
Functional respiratory imaging and contract research services are provided.
|
|
| Locked | Locked | Locked |
Medical devices and radiopharmaceuticals for lung imaging are developed.
|
|
| Locked | Locked | Locked |
Provider of software for lung cancer diagnosis
|
Detailed competitors of Bioxydyn
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bioxydyn
Complete news archive for Bioxydyn
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bioxydyn
Bioxydyn was founded in 2009 and raised its 1st funding round 3 years after it was founded.
Bioxydyn is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Bioxydyn is a funded company, having raised a total of $1.93M across 1 funding round to date.
As of Dec 31, 2021, the latest employee count at Bioxydyn is 8.
Founded in 2009 and based in Manchester, United Kingdom, BiOxyDyn operates in the medical imaging sector, focusing on tools for respiratory conditions like COPD and asthma. Imaging services, including oxygen-enhanced MRI for lung oxygenation, dynamic contrast-enhanced MRI for perfusion analysis, and diffusion MRI for tissue structure assessment, are provided. A combined package named Pulmolux targets respiratory disorders. As a contract research organization, clinical diagnostic solutions are being developed.
Bioxydyn's top competitors include Fluidda, Polarean Imaging and Tomophase.
Bioxydyn offers Quantitative Imaging Services, Respiratory Imaging, Cancer Imaging, Inflammation Imaging, and 2 more products and services.
Bioxydyn has 2 investors. Key investors include The North West Fund, and MTI Partners.